Crispr Therapeutics AG (CRSP)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$4.38B
EV to revenue ratio (TTM)
144.12
EV to ebitda
14.16
Financial Performance
Revenue (TTM)
$0.03B
Gross profit (TTM)
-$0.45B
EBITDA
-$0.50B
Profitability
Operating margin (TTM)
-934.00%
Profit margin
<0.01%
Return on assets (TTM)
-13.50%
Return on equity (TTM)
-25.60%
Per Share Metrics
Revenue per share (TTM)
$0.26
EPS
-$4.73
Diluted EPS (TTM)
-$4.73
Book value
$17.02
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
n/a
Trailing P/E
n/a
Forward P/E
23.36
PEG ratio
-0.21
Price to sales ratio (TTM)
173.99
Price to book ratio (TTM)
2.95
Growth
Quarterly earnings growth (YoY)
1,325.00%
Quarterly revenue growth (YoY)
<0.01%
Analyst Sentiment
Strong buy
4
Buy
9
Hold
10
Sell
0
Strong sell
0
Risk & Volatility
Beta
1.90